Medical and surgical treatment of rhino-orbital-cerebral mucormycosis in a child with leukemia | Canada Hyperbarics Skip to main content
Case Report Am J Ophthalmol Case Rep 2021

Medical and surgical treatment of rhino-orbital-cerebral mucormycosis in a child with leukemia

Levinsen M, Kiilgaard J, Thomsen C, Heegaard S, Nissen K — Am J Ophthalmol Case Rep, 2021

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented a case report detailing the aggressive medical and surgical treatment of a 3-year-old girl with leukemia who developed a severe fungal infection called rhino-orbital-cerebral mucormycosis (ROCM).

What They Found

The patient received a comprehensive treatment plan including systemic antifungal therapy, hyperbaric oxygen, and extensive surgeries such as orbital exenteration, skull base resection, and cerebral debridement. Despite the severe progression to cerebral involvement and orbital apex syndrome, the patient recovered and remained in complete remission from ROCM after 5 years.

What This Means for Canadian Patients

This case demonstrates that even severe rhino-orbital-cerebral mucormycosis in immunocompromised children can be successfully treated with an aggressive, multi-modal approach, which included hyperbaric oxygen therapy. It offers hope that a combination of medical and surgical interventions can lead to positive outcomes for patients facing this rare and life-threatening infection.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a single case report, these findings may not be generalizable to all patients with rhino-orbital-cerebral mucormycosis.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 34095606
Year Published 2021
Journal Am J Ophthalmol Case Rep

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.